Your browser doesn't support javascript.
loading
Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma.
Han, Fang; Liu, Junwei; Chu, Hongwu; Cao, Dan; Wu, Jia; Fu, Hong; Guo, Anyang; Chen, Weiqin; Xu, Yingping; Cheng, Xiangdong; Zhang, Yuhua.
Afiliación
  • Han F; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Liu J; Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Chu H; Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Cao D; Department of Medicine, Qingdao University, Qingdao, China.
  • Wu J; College of Food and Pharmacy, Zhejiang Ocean University, Zhoushan, China.
  • Fu H; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Guo A; Hepatobiliary and Pancreatic Surgery Dept., Shaoxing Peoples's Hospital, Shaoxing, China.
  • Chen W; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Xu Y; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Cheng X; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Zhang Y; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Front Oncol ; 12: 860084, 2022.
Article en En | MEDLINE | ID: mdl-36119539

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza